Drug Profile
Epoetin biosimilar - Zydus Cadila
Alternative Names: EPO - Zydus CadilaLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Zydus Cadila
- Class Antianaemics; Polyethylene glycols; Recombinant erythropoietins; Recombinant fusion proteins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 25 Mar 2014 Launched for Anaemia in India (IV)
- 25 Mar 2014 Launched for Anaemia in India (SC)